Real‐time monitoring of quality attributes by in‐line Fourier transform infrared spectroscopic sensors at ultrafiltration and diafiltration of bioprocess

Technologies capable of monitoring product quality attributes and process parameters in real time are becoming popular due to the endorsement of regulatory agencies and also to support the agile development of biotherapeutic pipelines. The utility of vibrational spectroscopic techniques such as Fourier transform mid‐infrared (Mid‐IR) and multivariate data analysis (MVDA) models allows the prediction of multiple critical attributes simultaneously in real time. This study reports the use of Mid‐IR and MVDA model sensors for monitoring of multiple attributes (excipients and protein concentrations) in real time (measurement frequency of every 40 s) at ultrafiltration and diafiltration (UF/DF) unit operation of biologics manufacturing. The platform features integration of fiber optic Mid‐IR probe sensors to UF/DF set up at the bulk solution and through a flow cell at the retentate line followed by automated Mid‐IR data piping into a process monitoring software platform with pre‐loaded partial least square regression (PLS) chemometric models. Data visualization infrastructure is also built‐in to the platform so that upon automated PLS prediction of excipients and protein concentrations, the results were projected in a graphical or numerical format in real time. The Mid‐IR predicted concentrations of excipients and protein show excellent correlation with the offline measurements by traditional analytical methods. Absolute percent difference values between Mid‐IR predicted results and offline reference assay results were ≤5% across all the excipients and the protein of interest; which shows a great promise as a reliable process analytical technology tool.

[1]  Kristen A. Severson,et al.  Opportunities and challenges of real‐time release testing in biopharmaceutical manufacturing , 2017, Biotechnology and bioengineering.

[2]  Sundaram Gunasekaran,et al.  FTIR spectroscopic evaluation of sucrose-maltodextrin-sodium citrate bioglass , 2017 .

[3]  J. Kong,et al.  Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy , 2015, Nature Protocols.

[4]  Harald Kolmar,et al.  At-line mid infrared spectroscopy for monitoring downstream processing unit operations , 2015 .

[5]  Jonida Basha,et al.  Effect of protein and solution properties on the donnan effect during the ultrafiltration of proteins , 2011, Biotechnology progress.

[6]  Pablo Rolandi,et al.  Mechanistic model of pH and excipient concentration during ultrafiltration and diafiltration processes of therapeutic antibodies , 2020, Biotechnology progress.

[7]  David Chilin,et al.  Applying process analytical technology to biotech unit operations , 2006 .

[8]  Jürgen Hubbuch,et al.  Multi-attribute PAT for UF/DF of Proteins—Monitoring Concentration, particle sizes, and Buffer Exchange , 2020, Analytical and Bioanalytical Chemistry.

[9]  George Karypis,et al.  Mining bioprocess data: opportunities and challenges. , 2008, Trends in biotechnology.

[10]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2018 , 2018, Nature Biotechnology.

[11]  Bas Diepenbroek,et al.  Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitations. , 2014, Trends in biotechnology.

[12]  Cenk Undey,et al.  Applied Advanced Process Analytics in Biopharmaceutical Manufacturing: Challenges and Prospects in Real-time Monitoring and Control , 2010 .

[13]  Theodore W Randolph,et al.  Protein-solute interactions affect the outcome of ultrafiltration/diafiltration operations. , 2004, Journal of pharmaceutical sciences.

[14]  Sergei G. Kazarian,et al.  In-column ATR-FTIR spectroscopy to monitor affinity chromatography purification of monoclonal antibodies , 2016, Scientific Reports.

[15]  Sanchayita Ghose,et al.  Technology outlook for real‐time quality attribute and process parameter monitoring in biopharmaceutical development—A review , 2020, Biotechnology and bioengineering.

[16]  Anurag S Rathore,et al.  Quality by Design (QbD)-Based Process Development for Purification of a Biotherapeutic. , 2016, Trends in biotechnology.

[17]  A S Rathore,et al.  Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications , 2010, Biotechnology and bioengineering.

[18]  S. Heissler,et al.  In-line Fourier-transform infrared spectroscopy as a versatile process analytical technology for preparative protein chromatography. , 2018, Journal of chromatography. A.

[19]  Harald Kolmar,et al.  Matrix effects during monitoring of antibody and host cell proteins using attenuated total reflection spectroscopy , 2013, Biotechnology progress.

[20]  Chris Morris,et al.  The Preeminence of Multivariate Data Analysis as a Statistical Data Analysis Technique in Pharmaceutical R&D and Manufacturing , 2018 .

[21]  P. Mitchell,et al.  Assessment of polygenic effects links primary open-angle glaucoma and age-related macular degeneration , 2016, Scientific Reports.

[22]  Anurag S Rathore,et al.  Roadmap for implementation of quality by design (QbD) for biotechnology products. , 2009, Trends in biotechnology.

[23]  A S Rathore,et al.  Process analytical technology (PAT) for biopharmaceutical products , 2010, Analytical and bioanalytical chemistry.